FRANCES SCHMIDT: Open Payments
NPI 1710602081 · MCCOMB, MS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$570 in 23 payments from 9 companies in 2025. Trend: 2023 $276 · 2024 $419 · 2025 $570
Food & beverage: $480Education: $90
| Company | Payments | Amount |
|---|---|---|
| LEO Pharma Inc. | 4 | $115 |
| ABBVIE INC. | 6 | $114 |
| Janssen Biotech, Inc. | 1 | $90 |
| Almirall LLC | 3 | $62 |
| Novartis Pharmaceuticals Corporation | 3 | $59 |
| UCB, Inc. | 2 | $53 |
| Botanix SB Inc | 2 | $39 |
| GENZYME CORPORATION | 1 | $20 |
| Medimetriks Pharmaceuticals, Inc. | 1 | $18 |
Products named: SKYRIZI, TREMFYA, ADBRY, COSENTYX, Bimzelx, Klisyri, SOFDRA, ANZUPGO.
Industry payments across MS — which companies pay providers there.
